MIRROR trial: Phase III investigation of muscle-derived stem cells (MyoCell) in patients with heart failure.

Trial Profile

MIRROR trial: Phase III investigation of muscle-derived stem cells (MyoCell) in patients with heart failure.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Jul 2013

At a glance

  • Drugs Muscle-derived autologous stem cell therapy Bioheart (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms MIRROR
  • Most Recent Events

    • 04 Jul 2013 New trial record
    • 03 Jul 2013 The first patient has been enrolled and randomised at the Hospital Angeles, Mexico, according to a Bioheart media release. Enrollment is expected to take 12 months.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top